SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-10-032267
Filing Date
2010-08-09
Accepted
2010-08-09 14:38:12
Documents
6
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 CAPSTONE THERAPEUTICS CORP 10-Q 6-30-2010 form10-q.htm 10-Q 409094
2 EXHIBIT 3-1 ex3-1.htm EX-3.1 103852
3 EXHIBIT 10-1 ex10-1.htm EX-10.1 14470
4 EXHIBIT 31-1 ex31-1.htm EX-31.1 13115
5 EXHIBIT 31-2 ex31-2.htm EX-31.2 14161
6 EXHIBIT 32 ex32.htm EX-32 7546
  Complete submission text file 0001140361-10-032267.txt   563808
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33560 | Film No.: 101001132
SIC: 2834 Pharmaceutical Preparations